Hepatitis B Vaccination and the Risk of Multiple Sclerosis
NEJM 344:327-332,372,381, Ascherio,A.,et al, 2001
Vaccinations and the Risk of Relapse in Multiple Sclerosis
NEJM 344:319-326,372, Confavreux,C.,et al, 2001
Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001
Vagus Nerve Stimulation and Drug Reduction
Neurol 56:561-563, Tatum,W.O.,et al, 2001
European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001
Treatment of Unruptured Cerebral Aneurysms in California
Stroke 32:597-605, Claibrone Johnston,S.,et al, 2001
Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001
Seizures in Multiple Sclerosis
Epilepsia 42:72-79, Sokic,D.V.,et al, 2001
Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001
Management of Chronic Tension-Type Headache with Tricyclic Antidepressant Medication, Stress Management Therapy, and Their Combination
JAMA 285:2208-2215, Holroyd,K.A.,et al, 2001
Identification and Prevention of Work-related Carpal Tunnel Syndrome
Lancet 357:1146-1147, Macfarlane,G.J., 2001
Epilepsy
NEJM 344:1145-1151, Browne,T.R. & Holmes,G.L., 2001
Differential Cognitive and Behavioral Effects of Carbamazepine and lamotrigine
Neurol 56:1177-1182, Meador, K.J.,et al, 2001
Atrial Fibrillation
NEJM 344:1067-1078, Falk,R.H., 2001
Cerebral Venous Thrombosis Presenting as Acute Visual Loss
Br J Ophthalmol 85:1139, Ko,Y.-C.,et al, 2001
Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
JAMA 283:2674-2679, Ross,G.W.,et al, 2000
North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000
Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000
Practice Parameter: Anticonvulsant Prophylaxis in Patients With Newly Diagnosed Brain Tumors
Neurol 54:1886-1893, Glantz,M.J.,et al, 2000
Decreasing Incidence of CNS AIDS-Defining Events Associated with Antiretroviral Therapy
Neurol 54:1856-1859, d'Arminion Monforte,A.,et al, 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Oral Zolmitriptan is Effective in the Acute Treatment of Cluster Headache
Neurol 54:1832-1839, Bahra,A.,et al, 2000
Secondary Prevention of Transient Ischaemic Attack and Stroke
BMJ 320:991-994, Lees,K.R.,et al, 2000
Risk Analysis of Treatment of Unruptured Aneurysms
JNNP 68:577-580, Mitchell,P.&Jakubowski,J., 2000
Functional Outcome and Quality of Life After Angiography and Operation for Unruptured Intracranial Aneurysms
JNNP 68:571-576, Raaymakers,T.W.M., 2000
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Measles,MMR, and Autism: The Confusion Continues
Lancet 355:1379, , 2000
Epilepsy in Elderly People
Lancet 355:1441-1446, Stephen,L.J.&Brodie,M.J., 2000
Managing Status Epilepticus
BMJ 320:953-954, Heafield,M.T.E., 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Magnetic Resonance Venography in Idiopathic Pseudotumor Cerebri
J Neuro-Ophthal 20:12-13, Lee,A.G.&Brazis,P.W., 2000
Influenza Vaccine and the Risk of Relapse of Guillain-Barre Syndrome
Neurol 55:452-453, Wijdicks,E.F.M. et al, 2000
Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000
Emerging Arboviral Encephalitis
BJM 321:1484-1485, Solomon,T., &Cardosa,M.J., 2000
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000
Carotid Endarterectomy, A Neurotherapeutic Advance
Arch Neurol 57:40-45, Barnett,H.J.M.&Meldrum,H.E., 2000
AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000
Effect of Endovascular Services and Hospital Volume on Cerebral Aneurysm Treatment Outcomes
Stroke 31:111-117, Johnston,S.C., 2000
Physical Activity and Stroke Mortality in Women, Ten-Year Follow-Up of the Nord-Trondelag Health Survey, 1984-1986
Stroke 31:14-18, Ellekjaer,H.,et al, 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Effect of Interferon B-1b in MS, Assessment of Annual Accumulation of PD/T2 Activity on MRI
Neurol 54:200-206, Zhao,G.J.,et al, 2000
Eletriptan in Acute Migraine:A Double-Blind,Placebo-Controlled Comparison to Sumatriptan
Neurol 54:156-163, Goadsby,P.J.,et al, 2000
Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000
Diffusion- and Perfusion-Weighted MR Imaging of Dural Sinus Thrombosis
AJNR 21:68-73, Manzione,J.,et al, 2000
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000